Ganciclovir exposure under a 450 mg daily dosage of valganciclovir for cytomegalovirus prevention in kidney transplantation: a prospective study. [electronic resource]
Producer: 20110331Description: 794-800 p. digitalISSN:- 1399-0012
- Adult
- Aged
- Antiviral Agents -- administration & dosage
- Cytomegalovirus -- drug effects
- Cytomegalovirus Infections -- prevention & control
- Female
- Ganciclovir -- administration & dosage
- Glomerular Filtration Rate
- Humans
- Kidney Transplantation
- Male
- Middle Aged
- Prospective Studies
- Survival Rate
- Tissue Distribution
- Valganciclovir
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.